Antimicrobial Agents Practice Questions

Q: What is the first-line treatment for syphilis?

Penicillin G. ***Penicillin G*** - **Penicillin G** is the **drug of choice** for all stages of syphilis due to its high efficacy against *Treponema pallidum*. - Its long duration of action, particularly **benzathine penicillin G**, provides sustained treponemicidal levels for early syphilis and prevents neurosyphilis progression. *Rifampicin* - **Rifampicin** is primarily used in the treatment of **tuberculosis** and other mycobacterial infections. - It has no significant role in the treatment of syphilis and is not effective against *Treponema pallidum*. *Tetracycline* - **Tetracycline** can be used as an **alternative treatment** for syphilis in patients with penicillin allergy. - However, it is not considered first-line due to potential side effects and the need for longer treatment courses compared to penicillin. *Erythromycin* - **Erythromycin** is an older macrolide antibiotic that can be used as an **alternative treatment for early syphilis** in penicillin-allergic pregnant patients. - Its efficacy is less reliable than penicillin G, and it is not recommended for later stages of syphilis or in non-pregnant individuals due to increasing resistance.

Q: Which class of antiretroviral drug does Nevirapine belong to?

NNRTI. ***NNRTI*** - **Nevirapine** is a first-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the treatment of HIV-1 infection. - **NNRTIs** bind directly to the reverse transcriptase enzyme at a site distinct from the active site, causing a conformational change that inactivates the enzyme and prevents viral DNA synthesis. - Other examples include **efavirenz, etravirine, and rilpivirine**. *NRTI* - **NRTIs** (nucleoside/nucleotide reverse transcriptase inhibitors) are prodrugs that require intracellular phosphorylation to active triphosphate forms. - They act as competitive inhibitors of reverse transcriptase and cause chain termination when incorporated into viral DNA. - Examples include **zidovudine, lamivudine, tenofovir, and emtricitabine**. *PI* - **PIs** (Protease Inhibitors) block the HIV protease enzyme, preventing cleavage of viral polyproteins into functional proteins. - This results in the production of immature, non-infectious viral particles. - Examples include **ritonavir, atazanavir, darunavir, and lopinavir**. *INSTI* - **INSTIs** (Integrase Strand Transfer Inhibitors) block the HIV integrase enzyme, preventing integration of viral DNA into the host chromosome. - This prevents establishment of permanent infection in the host cell. - Examples include **raltegravir, dolutegravir, and bictegravir**.

Q: Which second-line AKT drug is known to cause peripheral neuropathy?

Ethionamide. ***Ethionamide*** - **Ethionamide** is a second-line anti-tuberculosis drug known to cause a variety of dose-dependent adverse effects, including **peripheral neuropathy**. - This side effect is thought to be due to its structural similarity to **isoniazid**, another anti-tuberculosis drug that commonly causes neuropathy through **pyridoxine (vitamin B6) deficiency**. *Rifabutin* - **Rifabutin** is a rifamycin derivative primarily used as a second-line agent for multi-drug resistant tuberculosis and in patients with HIV to prevent *Mycobacterium avium* complex (MAC) infection. - Its main side effects include **gastrointestinal upset**, **rash**, and **neutropenia**, and it is not typically associated with peripheral neuropathy. *PAS (Para-aminosalicylic acid)* - **PAS** is an older second-line anti-tuberculosis drug that primarily causes **gastrointestinal disturbances** such as nausea, vomiting, diarrhea, and abdominal pain. - It can also lead to **hypersensitivity reactions** and **drug-induced hepatitis**, but **peripheral neuropathy** is not a characteristic side effect. *Moxifloxacin* - **Moxifloxacin** is a fluoroquinolone antibiotic used in the treatment of tuberculosis, including multi-drug resistant strains. - Although fluoroquinolones, as a class, can rarely cause peripheral neuropathy, it is not a prominent or distinguishing side effect of moxifloxacin in the context of second-line anti-tuberculosis drugs compared to ethionamide.

Q: Sudha, a 20-year-old female, developed antibiotic-associated pseudomembranous colitis caused by Clostridium difficile. Among the following drugs, which is most likely to be effective in the treatment of this disease?

Metronidazole. ***Metronidazole*** - Among the options listed, **Metronidazole** is the most effective for treating **Clostridioides difficile infection (CDI)**. - It works by disrupting bacterial DNA synthesis and is highly effective against **anaerobic bacteria** like *C. difficile*. - **Note:** Current guidelines (IDSA/SHEA 2021) recommend **oral vancomycin or fidaxomicin as first-line therapy**, with metronidazole reserved for situations where preferred agents are unavailable. However, among the drugs listed here, metronidazole remains the correct choice. *Ampicillin* - **Ampicillin** is a penicillin-class antibiotic and is **ineffective** against *Clostridioides difficile*. - It is one of the antibiotics that can **trigger** antibiotic-associated pseudomembranous colitis by disrupting normal gut flora and promoting *C. difficile* overgrowth. *Clindamycin* - **Clindamycin** is notorious for being a common cause of **antibiotic-associated pseudomembranous colitis** due to *Clostridioides difficile*. - It would **exacerbate** rather than treat the condition, making it an inappropriate choice. *Chloramphenicol* - **Chloramphenicol** is a broad-spectrum antibiotic that is **not effective** for treating *Clostridioides difficile* infection. - Its use is limited due to significant side effects, including **bone marrow suppression** (aplastic anemia), and it is not a recommended treatment for CDI.

Q: A patient with a history of penicillin allergy is admitted with bacterial meningitis. After receiving intravenous antibiotics, she develops a severe reaction. Which of the following drugs is most likely responsible for her condition?

Vancomycin. ***Vancomycin*** - **Vancomycin infusion reaction** (formerly "red man syndrome") is a common adverse effect, especially with rapid intravenous administration, characterized by **flushing, rash, pruritus**, and sometimes **hypotension** or **angioedema**. - This reaction results from **non-IgE-mediated mast cell degranulation**, leading to histamine release, and is not directly related to penicillin allergy but can be mistaken for an allergic reaction. *Gentamicin* - Gentamicin is an **aminoglycoside** and is not typically associated with severe immediate hypersensitivity reactions like the one described. - Its main toxicities include **nephrotoxicity** and **ototoxicity**, often occurring with prolonged use or high concentrations. *Chloramphenicol* - Chloramphenicol is associated with serious but less common adverse effects such as **bone marrow suppression** (aplastic anemia) or **grey baby syndrome** in neonates. - It does not commonly cause acute, severe hypersensitivity reactions presenting as a rash and flushing. *Doxycycline* - Doxycycline is a **tetracycline antibiotic** and is generally well-tolerated, though it can cause photosensitivity, gastrointestinal upset, and esophageal irritation. - Like the other incorrect options, it does not typically induce acute, severe infusion reactions mimicking an allergic response in the way vancomycin does, especially in a penicillin-allergic patient.

Q: Which of the following antibiotics does not contain a beta-lactam ring?

Linezolid. ***Linezolid*** - **Linezolid** is an **oxazolidinone antibiotic**, which has a different chemical structure and mechanism of action compared to beta-lactams. - It works by inhibiting bacterial **protein synthesis** at the ribosomal level, specifically binding to the 23S ribosomal RNA of the 50S subunit. *Penicillin* - **Penicillin** is the prototypic **beta-lactam antibiotic**, characterized by a four-membered beta-lactam ring in its chemical structure [1]. - Its mechanism of action involves inhibiting **bacterial cell wall synthesis** by binding to penicillin-binding proteins (PBPs) [3]. *Cefotaxime* - **Cefotaxime** is a **third-generation cephalosporin**, which belongs to the beta-lactam class of antibiotics [1], [2]. - All cephalosporins, like penicillins, possess a **beta-lactam ring** essential for their antibacterial activity [3]. *Imipenem* - **Imipenem** is a **carbapenem antibiotic**, another class within the beta-lactam family [1]. - Like other beta-lactams, it contains a **beta-lactam ring** and acts by interfering with bacterial **cell wall synthesis** [3].

Q: Which of the following statements regarding pyrazinamide is FALSE?

One should discontinue treatment if hyperuricemia occurs. ***One should discontinue treatment if hyperuricemia occurs*** - While pyrazinamide commonly causes **hyperuricemia** by reducing renal excretion of uric acid, it rarely leads to **gouty arthritis** and is generally not an indication for discontinuing treatment. - Management typically involves symptomatic relief for any occurring gout attacks, rather than stopping the essential antituberculosis medication. *There is minimal cross resistance with INH* - Pyrazinamide and **isoniazid (INH)** have distinct mechanisms of action against *Mycobacterium tuberculosis*. - Resistance to one drug usually does not imply resistance to the other, making them effective combination partners in tuberculosis treatment. *Polyarthralgia is a common side effect* - **Polyarthralgia** is a frequently reported side effect of pyrazinamide, often thought to be related to its effect on uric acid metabolism. - This symptom is usually mild and self-limiting and does not typically require discontinuation of the drug. *It can cause hepatotoxicity* - Pyrazinamide is known to be **hepatotoxic**, and elevated liver enzymes are a common adverse effect. - Regular monitoring of **liver function tests** is recommended during treatment with pyrazinamide, and it may need to be discontinued if significant liver injury occurs.

Q: Pseudojaundice is seen during the treatment with which antituberculous agent?

Rifampicin. ***Rifampicin*** - **Rifampicin (Rifampin)** causes a benign, harmless **pseudojaundice** characterized by **orange-red discoloration of urine, tears, sweat, saliva, and soft contact lenses**. - This is due to the drug's natural **orange-red pigment** and its excretion in body fluids, NOT due to actual liver dysfunction or bilirubin accumulation. - Patients should be warned about this harmless side effect to avoid unnecessary concern. *Rifabutin* - **Rifabutin**, a rifamycin analog, also causes orange-red discoloration of body fluids similar to rifampicin. - However, **rifampicin is the classic drug** most commonly associated with the term "pseudojaundice" in standard pharmacology references. - Rifabutin is used as an alternative to rifampicin in certain situations (e.g., HIV patients on antiretrovirals). *Ethambutol* - **Ethambutol** is known for causing **optic neuritis (retrobulbar neuritis)**, leading to **red-green color blindness** and visual field defects. - It does not cause jaundice or pseudojaundice. *Pyrazinamide* - **Pyrazinamide** is associated with **hepatotoxicity**, which can manifest as elevated liver enzymes and, in severe cases, actual **jaundice** due to liver damage. - It does not cause pseudojaundice, which is a harmless discoloration without liver dysfunction.

Q: Lamivudine belongs to which class of antiretroviral drugs?

Nucleoside reverse transcriptase inhibitor. ***Nucleoside reverse transcriptase inhibitor*** - **Lamivudine** is a synthetic nucleoside analog that competitively inhibits **HIV-1 reverse transcriptase**, incorporating into the viral DNA and leading to chain termination [1]. - As a **nucleoside reverse transcriptase inhibitor (NRTI)**, it requires intracellular phosphorylation to its active triphosphate form [1], [2]. *Nucleotide reverse transcriptase inhibitor* - **Nucleotide reverse transcriptase inhibitors (NtRTIs)** are structurally similar to nucleotides, meaning they already contain a phosphate group [2]. - They tend to have a **higher barrier to resistance** and include drugs like **tenofovir disoproxil fumarate** (TDF) and **tenofovir alafenamide** (TAF). *Non-nucleoside reverse transcriptase inhibitor* - **Non-nucleoside reverse transcriptase inhibitors (NNRTIs)** bind directly to a **hydrophobic pocket** on the reverse transcriptase enzyme, causing a conformational change that inhibits its activity [4]. - Unlike NRTIs/NtRTIs, NNRTIs do not require phosphorylation to be active and do not act as **chain terminators** [1]. *Protease inhibitor* - **Protease inhibitors (PIs)** prevent the HIV protease enzyme from cleaving viral polyproteins into functional proteins, which are essential for the assembly of new infectious virions [3], [4]. - This class of drugs, such as **ritonavir** and **atazanavir**, interferes with the final maturation step of the virus [3].

Q: The combination of trimethoprim and sulfamethoxazole is effective against which of the following opportunistic infections in the AIDS patient?

Pneumocystis jirovecii. ***Pneumocystis jiroveci*** - **Pneumocystis pneumonia (PCP)**, caused by *Pneumocystis jirovecii*, is a common and severe opportunistic infection in AIDS patients. - ** Trimethoprim-sulfamethoxazole (TMP-SMX)**, also known as Bactrim, is the **drug of choice** for both treatment and prophylaxis of PCP [1], [2]. *Disseminated Herpes simplex infection* - **Herpes simplex virus (HSV)** infections are typically treated with antiviral medications like **acyclovir, valacyclovir, or famciclovir**. - TMP-SMX has **no antiviral activity** and is ineffective against HSV. *Cryptococcal meningitis infection* - **Cryptococcal meningitis** is a fungal infection primarily treated with **amphotericin B** in combination with **flucytosine**, followed by fluconazole for maintenance. - TMP-SMX is **not active** against *Cryptococcus neoformans*. *Tuberculosis infection* - **Tuberculosis (TB)**, caused by *Mycobacterium tuberculosis*, requires a **multi-drug regimen** typically including isoniazid, rifampin, pyrazinamide, and ethambutol [3]. - While TMP-SMX has some activity against *Nocardia spp.* and some atypical mycobacteria, it is **not effective** for the treatment of *Mycobacterium tuberculosis*.

Question 1

What is the first-line treatment for syphilis?

Accepted Answer

Penicillin G

Answer

Tetracycline

Answer

Erythromycin

Answer

Rifampicin

Question 2

Which class of antiretroviral drug does Nevirapine belong to?

Accepted Answer

NNRTI

Answer

NRTI

Answer

INSTI

Answer

PI

Question 3

Which second-line AKT drug is known to cause peripheral neuropathy?

Accepted Answer

Ethionamide

Answer

Rifabutin

Answer

PAS

Answer

Moxifloxacin

Question 4

Sudha, a 20-year-old female, developed antibiotic-associated pseudomembranous colitis caused by Clostridium difficile. Among the following drugs, which is most likely to be effective in the treatment of this disease?

Accepted Answer

Metronidazole

Answer

Ampicillin

Answer

Clindamycin

Answer

Chloramphenicol

Question 5

A patient with a history of penicillin allergy is admitted with bacterial meningitis. After receiving intravenous antibiotics, she develops a severe reaction. Which of the following drugs is most likely responsible for her condition?

Accepted Answer

Vancomycin

Answer

Chloramphenicol

Answer

Gentamicin

Answer

Doxycycline

Question 6

Which of the following antibiotics does not contain a beta-lactam ring?

Accepted Answer

Linezolid

Answer

Penicillin

Answer

Cefotaxime

Answer

Imipenem

Question 7

Which of the following statements regarding pyrazinamide is FALSE?

Accepted Answer

One should discontinue treatment if hyperuricemia occurs

Answer

It can cause hepatotoxicity

Answer

There is minimal cross resistance with INH

Answer

Polyarthralgia is a common side effect

Question 8

Pseudojaundice is seen during the treatment with which antituberculous agent?

Accepted Answer

Rifampicin

Answer

Ethambutol

Answer

Pyrazinamide

Answer

Rifabutin

Question 9

Lamivudine belongs to which class of antiretroviral drugs?

Accepted Answer

Nucleoside reverse transcriptase inhibitor

Answer

Nucleotide reverse transcriptase inhibitor

Answer

Non-nucleoside reverse transcriptase inhibitor

Answer

Protease inhibitor

Question 10

The combination of trimethoprim and sulfamethoxazole is effective against which of the following opportunistic infections in the AIDS patient?

Accepted Answer

Pneumocystis jirovecii

Answer

Disseminated Herpes simplex infection

Answer

Cryptococcal meningitis infection

Answer

Tuberculosis infection

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?